Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin

Journal of Nuclear Medicine

Volumn 45, Issue 12, 2004, Pages 2088-2094

  Siaens, Rien H ^a,d   Rennen, Huub J ^b   Boerman, Otto C ^b   Dierckx, Rudi ^c   Slegers, Guido ^a  

^a GHENT UNIVERSITY   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d NONE   (Belgium)

Author keywords

99mTc fluoroquinolones; Inflammation, infection imaging

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN TC 99M; ENROFLOXACIN; ENROFLOXACIN TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; QUINOLONE DERIVATIVE; TECHNETIUM; TECHNETIUM COMPLEX; TECHNETIUM TC 99M CIPROFLOXACIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG BINDING; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCINTILLATION CAMERA; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; ANIMAL; CANDIDIASIS; COMPARATIVE STUDY; METABOLISM; MICROBIOLOGY; SCINTISCANNING; STAPHYLOCOCCUS INFECTION; SYNTHESIS; THIGH; WISTAR RAT;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CIPROFLOXACIN; FLUOROQUINOLONES; ORGANOTECHNETIUM COMPOUNDS; QUINOLONES; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TECHNETIUM; THIGH;

EID: 16644381258     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233-235.
2. Britton KE, Vinjurami S. Clinical evaluation of technetium-99m Infecton for the localisation of bacterial infection. Eur J Nucl Med. 1997;24:553-556.
3. 99mTc-Ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun. 2002;23:167-170.
4. 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med. 2001;42:567-574.
5. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol. 1998;51:215-219.
6. 99mTc-ciprofloxacin (Infecton). J Clin Pathol. 2002;55:817-823.
7. Chianelli M, Mather SJ, Martin-Comin J, Signore A. Radiopharmaceuticals for the study of inflammatory processes: a review. Nucl Med Commun. 1997;18:437-455.
8. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;20:384-393.
9. Chu TW, Fernandes PB. Structure-activity relationships of the fluoroquinolones. Antimicrob Agents Chemother. 1989;30:131-135.
10. Lecomte S, Baron MH, Chenon MT. The fluoroquinolones and their targets [in French]. Lett Sci Chim. 1999;68:16-17.
11. 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med. 1999;40:829-836.
12. Rennen HJJM, Boerman OC, Oyen WJG, Corsten FHM. Imaging infection/inflammation in the new millennium. Eur J Nucl Med. 2001;28:241-252.
13. 99mTc-ciprofloxacin kit preparation. Nuklearmedizin. 2002;41:224-229.
14. Decristoforo C, Mather SJ. 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution. Nucl Med Biol. 1999;26:389-396.
15. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A. Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol Imaging. 2002;29:530-535.
16. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteaarticular diseases. J Nucl Med. 2003;44:920-926.
17. 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med. 2002;43:239-245.